mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |